interlocutory injunction introduction 1 on 12 september 2007 pharmaust limited (pharmaust) lodged with the australian securities and investments commission (asic) a prospectus for a 1:1 entitlement rights issue at 3 cents per share with a view to raising $3,550,618.
dr d'sylva, who was the ceo of cbi, became the managing director of pharmaust.
at the end of 2006 its subsidiaries were three companies, pharmaust manufacturing pty ltd (pharmaust manufacturing), epichem pty ltd (epichem) and mimotopes pty ltd (mimotopes).